Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2006.068437v1, 2006; 10.1373/clinchem.2006.068437
This Article
Right arrow Full Text (PDF)
Right arrow 068437.Supplemental Data: Example calculation
Right arrow All Versions of this Article:
clinchem.2006.068437v1
52/9/1685    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christenson, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christenson, R. H.

Received on February 8, 2006
Accepted on April 11, 2006

Proteomics and Protein Markers

Toward Standardization of Cardiac Troponin I Measurements Part II: Assessing Commutability of Candidate Reference Materials and Harmonization of Cardiac Troponin I Assays

Robert H. Christenson 1*, Show Hong Duh 2, Fred S. Apple 3, Geza S. Bodor 4, David M. Bunk 5, Mauro Panteghini 6, Michael J. Welch 7, Alan H.B. Wu 8, Stephen E. Kahn 9, for the American Association for Clinical Chemistry Cardiac Troponin I Standardization Committee

1 Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, and Member of the American Association for Clinical Chemistry Cardiac Troponin I Standardization Committee
2 Department of Pathology, University of Maryland School of Medicine, Baltimore, MD
3 Department of Laboratory Medicine and Pathology, Hennepin County Medical Center, and University of Minnesota School of Medicine, Minneapolis, MN, and Member of the American Association for Clinical Chemistry Cardiac Troponin I Standardization Committee
4 Denver Health Medical Center, Denver, CO, and Member of the American Association for Clinical Chemistry Cardiac Troponin I Standardization Committee
5 Analytical Chemistry Division, National Institute of Standards and Technology, Gaithersburg, MD
6 Dipartimento di Scienze Cliniche "Luigi Sacco", Universitè degli Studi di Milano, Milano, Italy, and Member of the American Association for Clinical Chemistry Cardiac Troponin I Standardization Committee
7 Analytical Chemistry Division, National Institute of Standards and Technology, Gaithersburg, MD, and Member of the American Association for Clinical Chemistry Cardiac Troponin I Standardization Committee
8 Department of Pathology and Laboratory Medicine, University of California at San Francisco, San Francisco, CA, and Member of the American Association for Clinical Chemistry Cardiac Troponin I Standardization Committee
9 Departments of Pathology, Cell Biology, Neurobiology and Anatomy, Loyola University Medical Center, Maywood, IL, and Chair, American Association for Clinical Chemistry Cardiac Troponin I Standardization Committee

* To whom correspondence should be addressed. E-mail: rchristenson{at}umm.edu.

Background: Cardiac troponin I (cTnI) measurements show a ~20- to 40-fold difference between assays, and better standardization and harmonization is needed. Toward this goal, the AACC cTnI Standardization Committee collaborated with National Institute of Standards and Technology (NIST) in an earlier study to select 2 candidate reference materials (cRMs).

Methods: Two troponin cRMs, a CIT complex from human heart tissue and a CIT complex from recombinant technology, were supplied to NIST to assess composition, purity, and cTnI value assignment. These cRMs and 6 cTnI-positive human serum pools were shipped to manufacturers of 15 cTnI assays. Commutability of the materials was examined by determining the numerical relationship for the cRM preparations between each manufacturer-specified field method and each of the other 14 field methods. These relationships were then compared with the corresponding numerical relationships for the human serum pools. Harmonization of methods was accomplished by determining regression parameters relative to the analytical system yielding values closest to the median for each serum pool. These regression parameters were used to recalculate pool values to harmonize the assays. Interassay CVs before and after harmonization were determined.

Results: Characterization of the CIT and CI cRMs showed that these materials were of specified composition. The proportion of cTnI methods that demonstrated commutability for the CIT cRM was 45%; for the CI cRM, 39% of methods demonstrated commutability. Interassay cTnI variability for the field methods ranged from 82% to 97%, median 88%. After harmonization, variability of the serum pools for the cTnI methods was decreased to between 9.0% and 23%, median 15.5%.

Conclusions: The proportion of methods demonstrating commutability was too low for use as a common calibrator for the cTnI field methods. However a simple strategy using serum pools can improve harmonization of field cTnI methods by over 5-fold. The CIT cRM was selected by the AACC cTnI standardization committee, and a new lot has been classified as the cTnI certified reference material Standard Reference Material 2921 by NIST.




The following articles in journals at HighWire Press have cited this article:


Home page
Lab MedHome page
M. Bonham and S. Miller
Clinical Comparison of 99th Percentile and 10% Coefficient of Variation Cutoff Values for Four Commercially Available Troponin I Assays
Lab Med, August 1, 2009; 40(8): 470 - 473.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. H. B. Wu
Gender-Specific Decision Limits for Cardiac Troponin for Risk Stratification?
Anesth. Analg., March 1, 2009; 108(3): 686 - 688.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
C.M. Cobbaert, C.W. Weykamp, E.C.H.J. Michielsen, H. Baadenhuijsen, and M.P. van Dieijen-Visser
Time-Dependent Instability of Cardiac Troponins in Human Plasma Spiked with NIST Reference Material 2921
Clin. Chem., December 1, 2008; 54(12): 2078 - 2079.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
G. Cattozzo, E. Guerra, F. Ceriotti, C. Franzini, and on behalf of the Enzyme Working Group of the Itali
Commutable Calibrator with Value Assigned by the IFCC Reference Procedure to Harmonize Serum Lactate Dehydrogenase Activity Results Measured by 2 Different Methods
Clin. Chem., August 1, 2008; 54(8): 1349 - 1355.
[Abstract] [Full Text] [PDF]


Home page
Ann Clin BiochemHome page
D. C Gaze and P. O Collinson
Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance
Ann Clin Biochem, July 1, 2008; 45(4): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
NACB Writing Group Members, F. S. Apple, R. L. Jesse, L. K. Newby, A. H.B. Wu, and R. H. Christenson
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary Syndromes
Circulation, April 3, 2007; 115(13): e352 - e355.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
NACB WRITING GROUP MEMBERS, F. S. Apple, R. L. Jesse, L. K. Newby, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, R. H. Christenson, F. S. Apple, C. P. Cannon, et al.
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary Syndromes
Clin. Chem., April 1, 2007; 53(4): 547 - 551.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Association for Clinical Chemistry.